For Immediate Release
Vantage Oncology, TriHealth Form Joint Venture To Deliver Radiation Oncology

(July 18, 2011,  Cincinnati OH) - TriHealth and Vantage Oncology formed a joint venture, effective July 1, 2011, to manage the radiation oncology services of the TriHealth Cancer Institute in addition to Vantage Oncology’s Cincinnati outpatient radiation oncology centers. The joint venture will add two additional outpatient radiation oncology centers in Mt. Airy and Eastgate to TriHealth’s existing two locations in Clifton and Montgomery.

“The joint venture is a major step forward in TriHealth’s design of an integrated delivery system that aligns hospitals, physicians and community resources in a strong collaboration that significantly impacts the quality of patient-centered care and also the health status of Greater Cincinnati overall,” said John S. Prout, TriHealth president and chief executive officer.

“This is an ideal collaboration that leverages both organizations’ reputations for clinical excellence, patient-centered focus, and compassionate care,” said Prout.

“The partnership between Vantage Oncology and TriHealth exemplifies the cooperative relationships among hospitals, physicians and specialty providers that will be required to advance the quality and effectiveness of cancer care,” said Michael Fiore, chief executive officer and co-founder of Vantage Oncology. “We look forward to working with TriHealth and its physicians, many of whom we have worked with before, for the benefit of the Cincinnati community.”
The joint venture operates Vantage Oncology’s InterCommunity Cancer Center in Mt. Airy and Eastgate Cancer Center in Eastgate. These two locations double TriHealth’s radiation oncology locations for patient convenience. Current TriHealth locations are Good Samaritan Hospital in Clifton and Bethesda Hospital MediCenter in Montgomery. The TriHealth locations are managed by the joint venture.

Oncology and cancer services been identified as a key service opportunity by TriHealth. Nationally, among all types of outpatient specialty care, cancer treatment in outpatient settings is expected to grow from 12 percent of the outpatient specialty market in 2010 to 22 percent by 2020.

TriHealth Cancer Institute is one of two specialty institutes announced by TriHealth in mid-May. TriHealth Heart Institute also was established. These new institutes leverage TriHealth’s regional leadership in aligning physicians – employed and independent, primary care and specialists – to develop a shared focus on excellence for each patient and the community as whole. The new institutes wield the power of the full TriHealth system, which has been named among the country’s Top 100 Most Integrated Health Networks 13 times.

About TriHealth

Bethesda and Good Samaritan Hospital joined together to form TriHealth in 1995, bringing together two of Cincinnati’s finest health care organizations. Through these two acute care hospitals and more than 50 other locations, TriHealth provides a wide range of clinical, educational, preventive, and social programs. TriHealth’s non-hospital services include physician practice management, fitness centers and fitness center management, occupational health centers, home health and hospice care. For more information about TriHealth, visit www/

About Vantage Oncology
Founded in October 2002, Vantage Oncology develops and operates radiation oncology centers of excellence through acquisitions and joint ventures. The company was founded because of a growing need among cancer patients, hospitals and physicians for easily accessible and advanced radiation treatment therapies. Vantage Oncology currently operates 43 treatment facilities in 12 regions throughout the United States. Vantage Oncology is led by a seasoned management team including Chief Executive Officer Michael Fiore, Medical Director Leslie Botnick, M.D., Chief Financial Officer Marshal Salomon and Chief Development Officer Mark Ahern. For more information about Vantage Oncology, visit


Trace Longo
Longo Communications
Tel: (949) 364-2821

Vantage Oncology
Marketing Department
Tel: (310) 335-5000